CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: To investigate if BM CD8+ CTLs reduce LSCs through perforin-mediated killing in CML, we coincubated LSCs in the presence of CD8+ CTLs derived from the BM of perforin-proficient and -deficient CML mice.